The Impact of Cumulative Depression Along the HIV Care Continuum in Women Living with HIV during the Era of Universal Antiretroviral Treatment

Jon C. Mills, Brian W. Pence, Andrew Edmonds, Adebola Adedimeji, Rebecca M. Schwartz, Seble Kassaye, Jennifer Cocohoba, Mardge H. Cohen, Gretchen Neigh, Margaret A. Fischl, Mirjam Colette Kempf, Adaora A. Adimora

Research output: Contribution to journalArticle

Abstract

Background:Data are limited on cumulative impacts of depression on engagement in care and HIV outcomes in women living with HIV (WLWH) during the era of universal antiretroviral therapy (ART). Understanding the relationship of accumulated depression with HIV disease management may help identify benefits of interventions to reduce severity and duration of depressive episodes.Setting:A cohort of WLWH (N = 1491) from the Women's Interagency HIV Study at 9 sites across the US.Methods:This longitudinal observational cohort study (2013-2017) followed WLWH for a maximum of 9 semiannual visits. Depression was quantified as a time-updated measure of percent of days depressed (PDD) created from repeated assessments using the Center for Epidemiologic Studies Depression scale. Marginal structural Poisson regression models were used to estimate the effects of PDD on the risks of missing an HIV care appointment, <95% ART adherence, and virological failure (≥200 copies/mL). Results:The risk of missing an HIV care appointment [risk ratio (RR) = 1.16, 95% confidence interval = 0.93 to 1.45; risk difference (RD) = 0.01, -0.01 to 0.03], being <95% ART adherent (RR = 1.27, 1.06-1.52; RD = 0.04, -0.01 to 0.07), and virological failure (RR = 1.09, 1.01-1.18; RD = 0.01, -0.01 to 0.03) increased monotonically with increasing PDD (comparing those with 25 to those with 0 PDD). The total effect of PDD on virological failure was fully (%100) mediated by being <95% ART adherent. Conclusions:Time spent depressed increases the risk of virological failure through ART adherence, even in the era of universal ART regimes forgiving of imperfect adherence.

Original languageEnglish (US)
Pages (from-to)225-233
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume82
Issue number3
DOIs
StatePublished - Nov 1 2019

Keywords

  • HIV
  • HIV care continuum
  • cumulative depression
  • mental illness

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'The Impact of Cumulative Depression Along the HIV Care Continuum in Women Living with HIV during the Era of Universal Antiretroviral Treatment'. Together they form a unique fingerprint.

  • Cite this

    Mills, J. C., Pence, B. W., Edmonds, A., Adedimeji, A., Schwartz, R. M., Kassaye, S., Cocohoba, J., Cohen, M. H., Neigh, G., Fischl, M. A., Kempf, M. C., & Adimora, A. A. (2019). The Impact of Cumulative Depression Along the HIV Care Continuum in Women Living with HIV during the Era of Universal Antiretroviral Treatment. Journal of Acquired Immune Deficiency Syndromes, 82(3), 225-233. https://doi.org/10.1097/QAI.0000000000002140